In 2010, both import and export of traditional Chinese medicine increased, and private enterprises became the main force

Business club, February 23 news with the gradual fading of the financial crisis, the global market demand for Chinese pharmaceutical products has picked up, China's pharmaceutical foreign trade has accelerated the pace of growth, and the increasingly popular international green concept has also provided a rare development opportunity for China's export of traditional Chinese medicine According to the latest customs statistics, in 2010, China's import and export volume of traditional Chinese medicine products reached 2.632 billion US dollars, up 22.74% year on year Among them, the export value was US $1.944 billion, up 22.78% year on year; the import value was US $688 million, up 22.61% year on year General situation of import and export of traditional Chinese Medicine In 2010, the export volume of plant extracts was US $815 million, a year-on-year increase of 17.62%, accounting for 41.92% of the total export volume of traditional Chinese medicine, and extracts remained the main export volume of traditional Chinese medicine; the import volume of extracts was US $130 million, a year-on-year increase of 7.16%, accounting for 18.95% of the total import volume of traditional Chinese medicine The export volume of Chinese herbal pieces was 776 million US dollars, an increase of 28.07% year on year, accounting for 39.89% of the total export volume of Chinese herbal products The export volume of Chinese patent medicine was 193 million US dollars, an increase of 18.05% year on year; the import volume was 218 million US dollars, an increase of 23.71% year on year The trade deficit of Chinese patent medicine began in 2008, and continued to increase in 2010 Except for 2006, the trade of health products has been in deficit from 2003 to 2010 In 2010, the export volume was US $161 million, up 32.27% year on year; the import volume was US $203 million, up 30.33% year on year Although the import and export of health care products increased the most year-on-year in the trade of traditional Chinese medicine, the deficit reached 42 million US dollars, a record high ASEAN, which is still dominated by traditional markets, has become a new bright spot Japan, Hong Kong, the United States and South Korea are still the main export markets of traditional Chinese medicine In 2010, the export growth rate exceeded 10% The export volume to these four markets accounts for 48.71% of the total export volume of traditional Chinese medicine The European Union is one of the world's largest vegetable drug markets and one of the main destinations for the export of Chinese patent medicines According to the directive on the registration procedure of traditional botanical drugs issued by the European Union on March 31, 2004, all botanical drugs sold in the European Union market must be registered in accordance with the new regulations before April 30, 2011, and obtain the listing permission Otherwise, the current circulation of traditional Chinese medicine in the EU market in the form of food and health products will be banned In 2010, China's exports of Chinese patent medicines to the EU amounted to US $12.5238 million, a year-on-year increase of only 15%, far lower than the annual growth rate of 25% of the exports of Chinese patent medicines to the EU in previous years Although faced with such problems as high registration cost, small market scale and slowing growth of export to the EU, some traditional Chinese medicine enterprises have not lost confidence in the EU market, and have begun to carry out relevant registration work China Medical Insurance chamber of commerce is also pushing for "Foreign Trade Development Promotion Fund" to support the project In January 2010, the China ASEAN Free Trade Area (CAFTA) agreement was officially implemented, and tariffs on traditional Chinese medicine trade between China and ASEAN countries were significantly reduced, making customs clearance more convenient As a result, in 2010, China's import and export of traditional Chinese medicine to ASEAN increased by 28.05% year-on-year to US $422 million, 6 percentage points higher than China's annual average growth rate of traditional Chinese medicine import and export Among them, exports reached 337 million US dollars, an increase of 26.97% year-on-year; imports reached 85 million US dollars, an increase of 32.55% year-on-year Malaysia, Vietnam and Singapore are the main export markets of Chinese traditional medicine, among which Malaysia mainly imports plant extracts from China, while Vietnam mainly imports Chinese herbal pieces Singapore has relatively perfect regulations on the registration of Chinese patent medicines, and the market of Chinese patent medicines is relatively mature, which has become one of the main destination countries of Chinese patent medicines exported to ASEAN In 2010, there were 3263 export enterprises of traditional Chinese medicine products, an increase of 332 compared with 2009 Private enterprises became the main export enterprises, accounting for 48.02% of the total export value, 29.12% of the total export value of "three capital" enterprises and 22.7% of the total export value of state-owned enterprises It is worth noting that among the private enterprises, the export volume of private enterprises accounts for more than 90% In 2010, there were 1591 enterprises engaged in the import of traditional Chinese medicine products, of which "three capital" enterprises imported US $302 million, accounting for 43.84%; private enterprises imported US $300 million, accounting for 43.64%; state-owned enterprises only imported US $85.58 million, accounting for 12.44% The export characteristics of Chinese herbal medicine: the price of Chinese herbal medicine has been rising throughout the year since the beginning of 2010, and the price of Chinese herbal medicine has been increasing significantly In the market, the price of 537 kinds of commonly used Chinese herbal medicines increased by 84%, generally between 5% and 180% Among them, the price increase of Radix Pseudostellariae is the most obvious, with an increase of 353% in the whole year; the price increase of Radix Codonopsis is up to 162%; the price increase of Radix Notoginseng is up to 68%; other traditional Chinese medicine varieties such as Cordyceps sinensis and Angelica have also increased in varying degrees The increase in the price of Chinese herbal medicines in China led to the increase in the export amount of Chinese herbal pieces In 2010, the export amount was US $509 million, up 25.9% year on year The average export price increased by 13.4% year-on-year, and the prices of some medicinal materials continued to increase, such as Fritillaria, by 454% year-on-year; Tianqi, by 245% year-on-year; Cordyceps, by 142% year-on-year; Coptis, by 61% year-on-year; Atractylodes, by 51% year-on-year But the trading volume of these Chinese herbal medicines with soaring prices generally shrank by 30% - 40% There are three main reasons for the sharp rise in the price of traditional Chinese medicine: first, in 2010, Southwest China experienced a series of natural disasters such as drought, flood and debris flow, which led to the reduction or even extinction of the production of traditional Chinese medicine, while the production and types of traditional Chinese Medicine in Southwest China accounted for more than 50% of the market share of traditional Chinese medicine, which directly led to the reduction of the supply of traditional Chinese medicine; second, the supply of traditional Chinese medicine The market demand of traditional Chinese medicine is constantly expanding, and the raw materials of health care products are mostly traditional Chinese medicine More and more people start to take traditional Chinese medicine health care products to regulate their bodies and prevent diseases, which makes the market scale of health care products industry in China continuously expanding, and the price of traditional Chinese medicine is rising At present, the market of health care products in China has ranked the second in the world Third, the speculation of hot money promotes the irrational growth of the price of traditional Chinese medicine Under the state's macro-control of the real estate market, the hot money withdrawn from the real estate market is no less than 300 billion yuan, part of which flows into the market of traditional Chinese medicine, hoarding, which directly leads to the rise of the price of traditional Chinese medicine Plant extracts: the export volume of plant extracts continued to increase by 17.62% year-on-year to US $815 million in 2010, which maintained the growth trend and has occupied the first place of export commodities of traditional Chinese medicine for many years The monthly export of plant extracts is basically stable, and the export volume remains at about 65 million US dollars, indicating that the demand for plant extracts in the international market is still strong From the perspective of export product structure, the largest increase in export amount is natural pigment products In terms of single variety, the export amount of Stevia extract increased significantly Among the top 10 enterprises, 3 enterprises mainly export Stevia extract In addition, paprika red pigment, lutein and other food pigments are also hot varieties for export growth in recent years Plant extract industry has a certain cluster effect, and the plant extract industry in each province has its own characteristics Shandong mainly produces plant extracts for food additives, while Zhejiang and Shanghai mainly produce plant extracts for medicinal and health products According to statistics, in 2010, the export volume of the main export food additives and fragrances and plant extracts increased significantly For example, Shandong and Jiangxi, the export of Stevia extract increased greatly, and the export of Yunnan flavor and fragrance increased significantly Provinces and cities that export plant extracts for medicinal and health products, such as Zhejiang and Beijing, saw a slight decline in exports In 2010, the main export markets of plant extracts in China are still Japan and the United States, with the export volume exceeding US $100 million, but the export growth rate has been in a weak state, both lower than 10% The most eye-catching is the EU market The EU countries, mainly Germany, France and the United Kingdom, imported plant extracts from China increased by more than 60% in 2010 Most of the products are used to produce plant medicine and food supplements EU countries need natural plant extracts to produce health products, food, beverage and natural health products, and the amount is very large, which provides a broad space for the export of plant extracts in China Especially in the face of the EU herbal medicine registration directive, most domestic Chinese medicine enterprises are difficult to complete the registration in the form of drugs in a short time From this point of view, it is also a way out for the EU to export herbal extracts In 2010, China's export of plant extracts to the European Union reached US $182 million, an increase of 49.15% year on year, far higher than the average increase of China's export of plant extracts However, it should also be noted that in recent years, the international requirements for heavy metals and pesticide residues have become increasingly strict, the production technology and product quality of Chinese herbal extracts need to be improved continuously, and the product structure needs to be further optimized Chinese patent medicine: the trade deficit increased in 2010, and the import and export of Chinese patent medicine reached 411 million US dollars, up 21% year on year Among them, the export is 193 million US dollars, and the import is 218 million US dollars The reverse balance is increasing In 2010, China's exports of Chinese patent medicines to 143 countries and regions, of which Singapore, Malaysia and Hong Kong increased significantly; Benin, Russia and South Korea decreased significantly In 2010, the main import sources of Chinese patent medicines were Germany, Hong Kong and Japan, among which the import growth from Germany and Japan reached 52.44% and 52.86% respectively Hong Kong, Japan and the United States are still the main export markets of Chinese patent medicines, accounting for about 57% of the total export of Chinese patent medicines Hong Kong is the region with the most concentrated export of Chinese patent medicines, accounting for 41.7% of the total, with an amount of US $80.49 million, an increase of about 19.53% year on year On the one hand, there is a strong demand for Chinese patent medicines in Hong Kong; on the other hand, some Hong Kong merchants have branches in the United States, Europe and other countries, and Hong Kong has become a transit station for the export of Chinese patent medicines to the world Health care products: the growth rate of import and export is obvious, and the deficit is still the same In 2010, the export of health care products in China was 161 million US dollars, a year-on-year increase of 32.27%; the import was 203 million US dollars, a year-on-year increase of 30.33% There are 98 export countries and regions, among which the United States, Vietnam and Indonesia have a large increase in export volume; Saudi Arabia and Hong Kong have a large decrease in export volume The United States and Japan are the main export countries of China's health products, accounting for more than 60% of health products exports In 2010, China's exports of health products to traditional markets such as North America and the European Union continued to increase However, in recent years, the export growth of health care products to Japan has slowed down, mainly due to Japan's strict requirements for specific health care food, making enterprises invest more in research and production, but the revenue is not large Some data show that the development of the whole healthy food market in Japan is not optimistic According to statistics, since 2005, the total market volume of healthy food in Japan has been gradually decreasing It is expected that the market will show a slow development trend before 2012, and the recovery of the whole market will be to 2013 In 2010, China's exports of health care products to Japan reached US $30.5 million, up only 2.59% year on year Influenced by the sluggish consumption of Japan's health care products market and the decrease of orders, China's health care products market to Japan in 2010